Our research focussed on the NHS cancer screening programmes and it is worth noting that while the effectiveness of cervical screening is well established for women over the age of 25 [17], there are still debates regarding the risks and benefits of breast cancer screening programmes [18], and even more uncertainty regarding the benefits of PSA tests in terms of prostate cancer screening [19]. This evidence concerns the gene KLK3 and breast carcinoma.